1-6 of 6
Gina L. Mazza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

Shivani Handa, Yosef Joseph Rene Amel Riazat-Kesh, Richard J Butterfield, Ganesh Sivakumar, Sangeetha Venugopal, Erin McGovern, Jonathan Feld, Douglas Tremblay, Sebastian Elghaity-Beckley, Marina Kremyanskaya, John O. Mascarenhas, Blake Langlais, Gina L. Mazza, Daniel I. Nathan, Joseph Tripodi, Vesna Najfeld, Amylou C Dueck, Raajit Rampal, Ronald Hoffman, Bridget Kelly Marcellino
Journal: Blood
Blood (2024) 144 (Supplement 1): 243.
https://doi.org/10.1182/blood-2024-206688
Published: 2024
Journal Articles

Trial in Progress - Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma

Anne W Beaven, Susan M. Geyer, Jonathon B. Cohen, Tycel Phillips, Travis Dockter, Priyanka A. Pophali, Gita Thanarajasingam, Gina L. Mazza, Alvaro J Alencar, Shira N. Dinner, Eric D. Hsi, Meng Welliver, Daniel Nikcevich, Brad S. Kahl, Jonathan W. Friedberg, Nancy L. Bartlett, John P. Leonard
Journal: Blood
Blood (2024) 144 (Supplement 1): 1661.3.
https://doi.org/10.1182/blood-2024-207372
Published: 2024
Journal Articles

Incorporating Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) into Dose Review in a Phase I Clinical Trial

Carolyn Mead-Harvey, Brie N Noble, Claire Yee, Gina L. Mazza, Blake Langlais, Sheetal Patel, Peter Trask, Lauren Rogak, Ethan Basch, Amylou C Dueck, Gita Thanarajasingam
Journal: Blood
Blood (2024) 144 (Supplement 1): 2299.
https://doi.org/10.1182/blood-2024-208089
Published: 2024
Journal Articles

Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care

Blake T. Langlais, MS, Carolyn Mead-Harvey, MS, Heidi E. Kosiorek, MS, Gina L. Mazza, PhD, Ruben Mesa, MD, Jeanne M. Palmer, MD, Amylou C. Dueck, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-143172
Published: 2020
Journal Articles

Symptom Burden and Quality of Life in High-Risk Essential Thrombocythemia and Polycythemia Vera Patients Receiving Hydroxyurea or Pegylated Interferon Alfa-2a: Results of Myeloproliferative Neoplasms Research Consortium (MPN-RC) 111 and 112 Trials

Gina L. Mazza, PhD, Carolyn Mead-Harvey, MS, John Mascarenhas, MD, Abdulraheem Yacoub, MD, Ronald Hoffman, MD, Heidi E. Kosiorek, MS, Josef T. Prchal, MD, Richard T. Silver, MD, Tiziano Barbui, MD, Amylou C. Dueck, PhD, Ruben Mesa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–21.
https://doi.org/10.1182/blood-2020-142817
Published: 2020
Journal Articles

Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score (MPN-SAF TSS)

Blake T. Langlais, MS, Heidi E. Kosiorek, MS, Gina L. Mazza, PhD, Carolyn Mead-Harvey, MS, Richard Butterfield, III, Jeanne M. Palmer, MD, Ruben Mesa, MD, Amylou C. Dueck, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-142838
Published: 2020